Amarendra Neppalli to Immunotherapy
This is a "connection" page, showing publications Amarendra Neppalli has written about Immunotherapy.
Connection Strength
0.035
-
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
Score: 0.035
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.